Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,151.00
Bid: 1,150.00
Ask: 1,152.00
Change: 1.00 (0.09%)
Spread: 2.00 (0.174%)
Open: 1,148.00
High: 1,154.00
Low: 1,144.00
Prev. Close: 1,150.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Syndicates 33 and 6104 – results and estimates

7 Mar 2024 07:30

RNS Number : 8915F
Hiscox Ltd
07 March 2024

Syndicates 33 and 6104 - results and estimates

Hamilton, Bermuda (07 March 2024) - Hiscox Ltd (LSE: HSX), the international specialist insurer, announces the final results for Syndicate 33 and Syndicate 6104 2021 account. It also announces the current estimates for Syndicate 33's 2022 and 2023 accounts, and Syndicate 6104's 2020, 2022 and 2023 accounts.

The results for 2021 account (excluding Members' Agent fee) expressed as a percentage of capacity, are as follows:

Syndicate

Year of account

Closing result

Previous estimate

Capacity

Hiscox share

33

2021

8.2%

1.1% to 11.1%

£1,699m

73%

6104

2021

4.1%

(5.9%) to 9.1%

£23m

0%

The estimates for 2020 (Syndicate 6104 only), 2022 and 2023 expressed as a percentage of capacity, are as follows:

Syndicate

Year of account

Current estimate

Previous estimate

Capacity

Hiscox share

33

2022

4.8% to 14.8%

4.4% to 14.4%

£1,699m

73%

33

2023

6.9% to 16.9%

N/A

£1,698m

73%

6104*

2020

22.4% to 32.4%

0.4% to 10.4%

£44m

0%

6104

2022

11.3% to 21.3%

9.9% to 19.9%

£13m

0%

6104

2023

19.7% to 29.7%

N/A

£19m

0%

* Syndicate 6104 2020 account remains open as at 31st December 2023.

ENDS

For further information:

Investors and analysts

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

Media

Eleanor Orebi Gann, Group Head of Communications, London +44 (0)207 081 4815

Tom Burns, Brunswick +44 (0)20 7404 5959

Simone Selzer, Brunswick +44 (0)20 7404 5959

Notes to editors

About The Hiscox Group

1. The Syndicates' estimates are after standard personal expenses, such as Managing Agent fees and profit commission and all charges levied directly on syndicates by Lloyd's, but before Members Agents' charges.

2. Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle.

The Hiscox Group employs over 3,000 people in 14 countries, and has customers worldwide. Through the retail businesses in the UK, Europe, Asia and the USA, we offer a range of specialist insurance for professionals and business customers as well as homeowners. Internationally traded, bigger ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
SYRBRGDXXDGDGSL
Date   Source Headline
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:01 amRNSAnnouncement of share repurchase programme
5th Mar 20247:00 amRNSFull Year Results
19th Feb 20245:48 pmRNSTR-1 Standard form-notification major shareholding
1st Feb 20244:34 pmRNSTotal Voting Rights
8th Jan 20243:07 pmRNSTotal Voting Rights
12th Dec 20234:44 pmRNSDirector/PDMR Shareholding
1st Dec 20234:40 pmRNSTotal Voting Rights
10th Nov 202311:30 amRNSSyndicates 33 and 6104 – results and estimates
8th Nov 20237:00 amRNSQ3 2023 Trading Statement
1st Nov 20235:20 pmRNSTotal Voting Rights
2nd Oct 20234:47 pmRNSTotal Voting Rights
27th Sep 20237:00 amRNSDivestment of DirectAsia
25th Sep 202312:30 pmRNSDirector/PDMR Shareholding
25th Sep 20239:00 amRNSApplication to be admitted to the Official List
12th Sep 20235:22 pmRNSAnnouncement of Scrip Reference Share Price
1st Sep 20237:00 amRNSDirector/PDMR Shareholding
11th Aug 20237:30 amRNSSyndicates 33 and 6104 - results and estimates
10th Aug 20237:00 amRNSDirector/PDMR Shareholding
4th Jul 20231:23 pmRNSTotal Voting Rights
21st Jun 20233:23 pmRNSDirector/PDMR Shareholding
16th Jun 202312:35 pmRNSDirector PDMR Shareholding
14th Jun 20231:19 pmRNSStandard form for notification of major holdings
13th Jun 20232:28 pmRNSDirector/PDMR Shareholding
9th Jun 20231:56 pmRNSApplication to be Admitted to Official List
9th Jun 202312:19 pmRNSApplication to be Admitted to Official List
8th Jun 20237:00 amRNSIFRS 17 restated results 2022
1st Jun 20235:10 pmRNSTotal Voting Rights
1st Jun 202312:12 pmRNSAnnouncement of Scrip Reference Share Price
30th May 20234:05 pmRNSDirector/PDMR Shareholding
30th May 20237:00 amRNSHiscox appoints Jonathan Bloomer Chair designate
23rd May 20233:26 pmRNSTR-1:Standard form-notification major shareholding
22nd May 202312:25 pmRNSTR-1:Standard form-notification major shareholding
15th May 20231:01 pmRNSSyndicates 33 and 6104 – results and estimates
12th May 20237:01 amRNSHiscox appoints new Independent Non Exec Director
12th May 20237:00 amRNSAGM RESULTS
11th May 20235:33 pmRNSTR-1 Standard form-notification major shareholding
9th May 202312:23 pmRNSTR-1:Standard form-notification major shareholding
4th May 20237:00 amRNSQ1 2023 Trading Statement
2nd May 20235:00 pmRNSTotal Voting Rights
5th Apr 20232:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:08 pmRNSTotal Voting Rights
24th Mar 20231:30 pmRNSNotice of 2023 AGM & 2022 Annual Report & Accounts
22nd Mar 202311:03 amRNSDirector/PDMR Shareholding
9th Mar 20233:46 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSSyndicates 33 and 6104 – results and estimates
8th Mar 20237:01 amRNSFull Year Results
8th Mar 20237:00 amRNSRobert Childs to retire from the Board as Chairman
2nd Mar 20237:00 amRNSTotal Voting Rights to 28 February 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.